Last reviewed · How we verify

NCT05464927: VMP

Visualizing Vascular Mechanisms of Lipedema

Active, enrolled Last updated 27 April 2025
What this trial tests

trial in Lipedema in 110 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 September 2021
Primary endpoint
1 January 2027
1 January 2027

Quick facts

Lead sponsorUniversity of Virginia
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment110
Start date1 September 2021
Primary completion1 January 2027
Estimated completion1 January 2027
Sites1 location across United States

Conditions studied

Sponsor

University of Virginia

Who can join

Adults 18 to 80, female only, with Lipedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This work will address clinical unmet needs for patients with lipedema using advanced magnetic resonance imaging (MRI) methods, in sequence with portable clinical tools, by testing fundamental hypotheses regarding potential screening methods, lymphatic therapy, and vascular dysfunction in patients with lipedema.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Lipedema: Insights into Morphology, Pathophysiology, and Challenges.
    Poojari A, Dev K, Rabiee A. · · 2022 · cited 47× · PMID 36551837 · DOI 10.3390/biomedicines10123081
  2. Vascular changes and their implications in lipedema.
    Al-Ghadban S, Guo Y, Juskiewicz ZJ, Crescenzi R, et al · · 2026 · PMID 42181679 · DOI 10.3389/fcell.2026.1819443

Verify or expand the search:

Other recruiting trials for Lipedema

Currently open trials in the same condition.

Other University of Virginia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05464927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing